Loading ...

doxorubicin-encapsulated CPLA nanodroplets

Based on

1 Articles
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

chloroform

Type Single Compound
Formula CHCl3
Role core
2

doxorubicin hydrochloride

Dox HCl Dox*HCl
Type Single Compound
Formula C27H29NO11*HCl
Role loaded material
3

allyl-functionalized cationic polylactide

CPLA
Type Polymer
Formula
Role layer

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
MCF7 breast cancer cell

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • chloroform
  • allyl-functionalized cationic polylactide
  • doxorubicin hydrochloride
See all (4)
  1. ibx86tbnL5FoQLFAWh3pRvOixR5IMd7Ct1FXAjSfObfbfyCnRQLIeIHGZNF8lL0
  2. PujRFSCTEoDqTY2u9Igl2Ys6hHene7Sa1ZOGBQOp9h1iv11cp46BIrcuTMX6
  3. h0jHrWyEH0zQBqyaPfWgjFj9X6sHIaIEmf4onqPdaM
Product

doxorubicin-encapsulated CPLA nanodroplets

Hydrodynamic diameter: 14 - 28 nm

Medium: water

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial